Beijing Beilu Pharmaceutical Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Beijing Beilu Pharmaceutical cash flow conversion efficiency. Based on the latest financial reports, Beijing Beilu Pharmaceutical (300016) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.66 Million ≈ $10.93 Million USD) by net assets (CN¥2.37 Billion ≈ $346.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Beijing Beilu Pharmaceutical (2006–2024)

Cash flow conversion efficiency of Beijing Beilu Pharmaceutical from 2006 to 2024. This chart illustrates how Beijing Beilu Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Beijing Beilu Pharmaceutical stock quote for real-time trading data and today's change.

Beijing Beilu Pharmaceutical Cash Flow Conversion Ratio Explained

Beijing Beilu Pharmaceutical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Beijing Beilu Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Beilu Pharmaceutical ranked by their cash flow conversion efficiency. Also see 300016 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
eXp World Holdings, Inc. NASDAQ:AGNT	0.138x
SLR Investment Corp NASDAQ:SLRC	0.017x
Guangan SHG:600979	0.038x
Red River Bancshares Inc NASDAQ:RRBI	0.032x
Olema Pharmaceuticals Inc NASDAQ:OLMA	-0.096x
ADLINK Technology Inc TW:6166	0.098x
Skipper Limited NSE:SKIPPER	0.092x
Fitipower Integrated Technology Inc TW:4961	0.004x

Annual Cash Flow Conversion Efficiency for Beijing Beilu Pharmaceutical (2006–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Beilu Pharmaceutical from 2006 to 2024. Review how much free cash does Beijing Beilu Pharmaceutical generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.83 Billion ≈ $267.71 Million	CN¥163.02 Million ≈ $23.86 Million	0.089x	+172.27%
2023-12-31	CN¥1.79 Billion ≈ $261.39 Million	CN¥58.46 Million ≈ $8.55 Million	0.033x	-50.75%
2022-12-31	CN¥1.92 Billion ≈ $281.43 Million	CN¥127.81 Million ≈ $18.70 Million	0.066x	+27.42%
2021-12-31	CN¥2.08 Billion ≈ $305.05 Million	CN¥108.73 Million ≈ $15.91 Million	0.052x	-43.93%
2020-12-31	CN¥1.89 Billion ≈ $276.87 Million	CN¥176.00 Million ≈ $25.75 Million	0.093x	-13.95%
2019-12-31	CN¥1.45 Billion ≈ $212.25 Million	CN¥156.81 Million ≈ $22.95 Million	0.108x	-25.83%
2018-12-31	CN¥1.21 Billion ≈ $176.45 Million	CN¥175.75 Million ≈ $25.72 Million	0.146x	+7.54%
2017-12-31	CN¥1.07 Billion ≈ $156.46 Million	CN¥144.92 Million ≈ $21.21 Million	0.136x	+60.46%
2016-12-31	CN¥901.69 Million ≈ $131.95 Million	CN¥76.17 Million ≈ $11.15 Million	0.084x	-2.56%
2015-12-31	CN¥932.63 Million ≈ $136.47 Million	CN¥80.85 Million ≈ $11.83 Million	0.087x	+37.19%
2014-12-31	CN¥666.33 Million ≈ $97.51 Million	CN¥42.11 Million ≈ $6.16 Million	0.063x	-14.55%
2013-12-31	CN¥559.38 Million ≈ $81.86 Million	CN¥41.37 Million ≈ $6.05 Million	0.074x	+69.54%
2012-12-31	CN¥523.96 Million ≈ $76.67 Million	CN¥22.86 Million ≈ $3.34 Million	0.044x	-53.12%
2011-12-31	CN¥491.47 Million ≈ $71.92 Million	CN¥45.73 Million ≈ $6.69 Million	0.093x	+15.98%
2010-12-31	CN¥467.62 Million ≈ $68.43 Million	CN¥37.51 Million ≈ $5.49 Million	0.080x	-39.92%
2009-12-31	CN¥433.71 Million ≈ $63.46 Million	CN¥57.91 Million ≈ $8.47 Million	0.134x	+473.67%
2008-12-31	CN¥133.23 Million ≈ $19.50 Million	CN¥-4.76 Million ≈ $-696.67K	-0.036x	-126.30%
2007-12-31	CN¥90.33 Million ≈ $13.22 Million	CN¥12.28 Million ≈ $1.80 Million	0.136x	-50.49%
2006-12-31	CN¥71.59 Million ≈ $10.48 Million	CN¥19.65 Million ≈ $2.88 Million	0.274x	--

About Beijing Beilu Pharmaceutical

SHE:300016 China Drug Manufacturers - Specialty & Generic

Market Cap

$658.93 Million

CN¥4.50 Billion CNY

Market Cap Rank

#10580 Global

#2819 in China

Share Price

CN¥8.00

Change (1 day)

+1.91%

52-Week Range

CN¥7.23 - CN¥11.19

All Time High

CN¥27.25